| The MEST score provides earlier risk prediction in lgA nephropathy SJ Barbour, G Espino-Hernandez, HN Reich, R Coppo, ISD Roberts, ... Kidney international 89 (1), 167-175, 2016 | 264 | 2016 |
| Energy and exergy analyses of a gasoline engine C Sayin, M Hosoz, M Canakci, I Kilicaslan International journal of energy research 31 (3), 259-273, 2007 | 166 | 2007 |
| Türkiye’de acil servise başvuran hastaların demografik özellikleri İ Kılıçaslan, H Bozan, C Oktay, E Göksu Türkiye Acil Tıp Dergisi 5 (1), 5-13, 2005 | 140 | 2005 |
| Lupus nephritis in children: prognostic significance of clinicopathological findings S Emre, I Bilge, A Sirin, I Kılıcaslan, A Nayır, F Oktem, V Uysal Nephron 87 (2), 118-126, 2001 | 122 | 2001 |
| Discrepancy between Gleason scores of biopsy and radical prostatectomy specimens IT Köksal, F Özcan, TC Kadıoğlu, T Esen, I Kılıçaslan, M Tunc European urology 37 (6), 670-674, 2000 | 121 | 2000 |
| Tuberculosis after renal transplantation: experience of one Turkish centre. A Yildiz, MS Sever, A Türkmen, T Ecder, F Beşişik, L Tabak, T Ece, ... Nephrology, dialysis, transplantation: official publication of the European …, 1998 | 94 | 1998 |
| Arterial changes in paediatric haemodialysis patients undergoing renal transplantation A Nayır, I Bilge, I Kiliçaslan, H Ander, S Emre, A Şirin Nephrology Dialysis Transplantation 16 (10), 2041-2047, 2001 | 64 | 2001 |
| Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy FP Schena, VW Anelli, J Trotta, T Di Noia, C Manno, G Tripepi, G D’Arrigo, ... Kidney international 99 (5), 1179-1188, 2021 | 61 | 2021 |
| The clinical significance of uric acid and complement activation in the progression of IgA nephropathy Y Caliskan, Y Ozluk, D Celik, N Oztop, A Aksoy, AS Ucar, H Yazici, ... Kidney and Blood Pressure Research 41 (2), 148-157, 2016 | 60 | 2016 |
| Comparison of disease characteristics, organ damage, and survival in patients with juvenile-onset and adult-onset systemic lupus erythematosus in a combined cohort from 2 … B Artim-Esen, S Şahin, E Çene, Y Şahinkaya, K Barut, A Adrovic, Y Özlük, ... The Journal of rheumatology 44 (5), 619-625, 2017 | 57 | 2017 |
| Up-regulation of TGM2 with ITGB1 and SDC4 is important in the development and metastasis of renal cell carcinoma M Erdem, S Erdem, O Sanli, H Sak, I Kilicaslan, F Sahin, D Telci Urologic Oncology: Seminars and Original Investigations 32 (1), 25. e13-25. e20, 2014 | 57 | 2014 |
| Expression of E-cadherin in prostate cancer in formalin-fixed, paraffin-embedded tissues: correlation with pathological features İT Köksal, F Özcan, I Kiliçaslan, A Tefekli Pathology 34 (3), 233-238, 2002 | 55 | 2002 |
| Elderly trauma: the two years experience of a university-affiliated emergency department. M Yildiz, MN Bozdemir, I Kiliçaslan, M Ateşçelik, Ş Gürbüz, B Mutlu, ... European Review for Medical & Pharmacological Sciences 16, 2012 | 49 | 2012 |
| The effect of squamous and/or glandular differentiation on recurrence, progression and survival in urothelial carcinoma of bladder F Erdemir, M Tunc, F Ozcan, BS Parlaktas, N Uluocak, I Kılıcaslan, ... International urology and nephrology 39, 803-807, 2007 | 48 | 2007 |
| Juvenile systemic lupus erythematosus in Turkey: demographic, clinical and laboratory features with disease activity and outcome S Sahin, A Adrovic, K Barut, N Canpolat, Y Ozluk, I Kilicaslan, S Caliskan, ... Lupus 27 (3), 514-519, 2018 | 47 | 2018 |
| Immunosuppressive treatment in C3 glomerulopathy: is it really effective? Y Caliskan, ES Torun, TO Tiryaki, A Oruc, Y Ozluk, SU Akgul, S Temurhan, ... American journal of nephrology 46 (2), 96-107, 2017 | 46 | 2017 |
| Efficacy of immunosuppressive therapy in IgA nephropathy presenting with isolated hematuria Ö Harmankaya, Y Öztürk, T Baştürk, A Öbek, I Kılıçarslan International urology and nephrology 33, 167-171, 2002 | 45 | 2002 |
| Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis O Mete, I Kilicaslan, MG Gulluoglu, V Uysal Virchows Archiv 447, 938-946, 2005 | 44 | 2005 |
| Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool SJ Barbour, M Canney, R Coppo, H Zhang, ZH Liu, Y Suzuki, K Matsuzaki, ... Kidney International 98 (4), 1009-1019, 2020 | 40 | 2020 |
| Impact of p53 and Ki‐67 in predicting recurrence and progression of superficial (pTa and pT1) urothelial cell carcinomas of urinary bladder N Kilicli‐Camur, I Kilicaslan, MG Gulluoglu, T Esen, V Uysal Pathology international 52 (7), 463-469, 2002 | 40 | 2002 |
